Considerations for choosing COVID-19 vaccine products
Content: This slide set summarizes WHO latest recommendations and considerations for choosing COVID-19 vaccine products with WHO Emergency Use List (EUL) (currently available under COVAX) as of 18 March 2022.
Objective: To help orient the Ministry of Health (MoH) and National Immunization Advisory Committee Group (NITAG) in their COVID-19 vaccine product choices to optimize their portfolio.
WHO HQ - Department of Immunization, Vaccines and Biologicals (IVB)
- Programme management
- Gavi, the Vaccine Alliance